DK3010484T3 - Injicerbare farmaceutiske præparater omfattende adrenalin og citronsyre - Google Patents

Injicerbare farmaceutiske præparater omfattende adrenalin og citronsyre Download PDF

Info

Publication number
DK3010484T3
DK3010484T3 DK14735841.0T DK14735841T DK3010484T3 DK 3010484 T3 DK3010484 T3 DK 3010484T3 DK 14735841 T DK14735841 T DK 14735841T DK 3010484 T3 DK3010484 T3 DK 3010484T3
Authority
DK
Denmark
Prior art keywords
adrenaline
citric acid
pharmaceutical preparations
injectable pharmaceutical
injectable
Prior art date
Application number
DK14735841.0T
Other languages
English (en)
Inventor
Philip Hansen
Pär Johansson
Jens Kindtler
Original Assignee
Fremont Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fremont Group Ltd filed Critical Fremont Group Ltd
Application granted granted Critical
Publication of DK3010484T3 publication Critical patent/DK3010484T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
DK14735841.0T 2013-06-17 2014-06-17 Injicerbare farmaceutiske præparater omfattende adrenalin og citronsyre DK3010484T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201370322 2013-06-17
PCT/DK2014/050171 WO2014202088A1 (en) 2013-06-17 2014-06-17 Injectable pharmaceutical compositions comprising adrenaline and citric acid

Publications (1)

Publication Number Publication Date
DK3010484T3 true DK3010484T3 (da) 2019-08-05

Family

ID=48672317

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14735841.0T DK3010484T3 (da) 2013-06-17 2014-06-17 Injicerbare farmaceutiske præparater omfattende adrenalin og citronsyre

Country Status (6)

Country Link
US (1) US9433589B2 (da)
EP (1) EP3010484B1 (da)
JP (1) JP2016521759A (da)
CN (1) CN105283170B (da)
DK (1) DK3010484T3 (da)
WO (1) WO2014202088A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170189352A1 (en) 2015-03-13 2017-07-06 Par Pharmaceutical, Inc. Epinephrine formulations
US9119876B1 (en) * 2015-03-13 2015-09-01 Par Pharmaceutical, Inc. Epinephrine formulations
AU2016321839B2 (en) * 2015-09-14 2021-05-27 Stayble Therapeutics Ab A composition for use in the treatment of intervertebral disc-related pain
IL266537B2 (en) 2016-11-15 2023-12-01 Klaria Pharma Holding Ab pharmaceutical preparation
WO2018140894A1 (en) 2017-01-30 2018-08-02 Nevakar, Inc Norepinephrine compositions and methods therefor
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
CN111163764A (zh) 2017-10-10 2020-05-15 默克专利股份公司 L-肾上腺素的稳定化可注射药物组合物
US10653646B2 (en) 2018-03-23 2020-05-19 Nevakar Inc. Epinephrine compositions and containers
GB201808462D0 (en) * 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
CN109528645A (zh) * 2018-12-29 2019-03-29 遂成药业股份有限公司 一种儿童用盐酸肾上腺素注射液及其制备方法
CN109998990B (zh) * 2019-04-30 2021-12-03 遂成药业股份有限公司 一种小规格盐酸肾上腺素注射液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0858803A4 (en) * 1995-08-28 2000-02-09 Showa Pharm Chem Ind COMPOSITION FOR LOCAL ANESTHESIA
FR2779061B1 (fr) * 1998-04-14 2004-08-20 Pharmatop Nouveau procede de stabilisation de composes phenoliques et les compositions pharmaceutiques en resultant
US20080269347A1 (en) 2006-09-28 2008-10-30 Azopharma, Inc. Epinephrine formulations
US8323695B2 (en) * 2007-08-13 2012-12-04 Mcneil-Ppc, Inc. Method for stabilizing phenylephrine
US20120029085A1 (en) 2010-07-29 2012-02-02 Mackay Jon Stabilization of quinol composition such as catecholamine drugs

Also Published As

Publication number Publication date
US20160113891A1 (en) 2016-04-28
WO2014202088A1 (en) 2014-12-24
CN105283170B (zh) 2019-10-18
EP3010484A1 (en) 2016-04-27
JP2016521759A (ja) 2016-07-25
CN105283170A (zh) 2016-01-27
EP3010484B1 (en) 2019-05-01
US9433589B2 (en) 2016-09-06

Similar Documents

Publication Publication Date Title
DK3010484T3 (da) Injicerbare farmaceutiske præparater omfattende adrenalin og citronsyre
DK3027204T3 (da) Flerdelte signaleringsproteiner og anvendelser deraf
DK3354282T3 (da) Glycan-terapeutiske midler og relaterede fremgangsmåder deraf
DK2963056T3 (da) Insulinanalog og anvendelse deraf
DK3019533T3 (da) Dobbeltspiraliserede immunoglobulinfusionproteiner og sammensætninger deraf
DK3043784T3 (da) Arylethere og anvendelser deraf
DK2951203T3 (da) Heterodimere proteiner
DK2970460T3 (da) Anti-IL-33-antistoffer og anvendelser deraf
DK2968443T3 (da) Hepcidinanaloger og anvendelser deraf
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
DK3003039T3 (da) Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser
BR112015001211A2 (pt) novos ácidos 5-aminotetra-hidroquinolina-2-carboxílicos e sua utilização
DK3063144T3 (da) Antiparasitære og pesticid-isoxazolinforbindelser
CL2015002750A1 (es) Anticuerpos humanos pac1
DK2962100T3 (da) Tuberkulosebiomarkører og anvendelser deraf
DK3011041T3 (da) Biodieselsammensætning og dermed forbundet fremgangsmåde og produkter
DK3041857T3 (da) Protein a-kromatografi
DK3029038T3 (da) Tetrazolinonforbindelse og anvendelse deraf
DK3027564T3 (da) Nedsænket forbrændingssmelter og fremgangsmåde
DK2964767T3 (da) Toksingener og fremgangsmåder til anvendelse deraf
DK2883954T3 (da) Peptidbibliotek og anvendelse deraf
DK3068505T3 (da) Spillesystem og -fremgangsmåde
DK3016547T3 (da) Dyrebarriere og fremgangsmåde
DK3003432T3 (da) Drivindretning til lægemiddeladministrationsanordning og lægemiddeladministrationsanordning
DK3079655T3 (da) Inhalerbare lægemidler